InsiderTrades

Form 4 for IMNM Immunome Inc.

Accepted 2024-08-19 00:00:00 ET · period of report 2024-08-15 · accession 0001415889-24-021656 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-08-19 2024-08-15 IMNM Higgins Jack CSO S - Sale+OE $13.93 -3,524 16.0K -18% -$49.1K
D 2024-08-19 2024-08-19 IMNM Higgins Jack CSO G - Gift $0.00 -2,471 13.5K -15% $0
D 2024-08-19 2024-08-15 IMNM Higgins Jack CSO M - OptEx $1.35 +19.5K 19.5K New +$26.4K
D 2024-08-19 2024-08-15 IMNM Higgins Jack CSO M - OptEx $0.00 -19.5K 179.0K -10% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-08-15 S D 3,524 $13.93 16,000 D — — (F2) The weighted average sale price for the transaction report was $13.925, and the range of prices were between $13.800 and $14.020. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
2 Common Common Stock 2024-08-19 G D 2,471 $0.00 13,529 D — —
3 Common Common Stock 2024-08-15 M A 19,524 $1.35 19,524 D — —
4 Derivative Stock option (right to buy) 2024-08-15 M D 19,524 $0.00 179,040 D $1.35 · — to 2032-06-23 19,524 Common Stock (F3) 25% of the shares vested on May 1, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter.